This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

WuXi PharmaTech (Cayman) Inc (WX)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 88.87M 54.13M 71.37M 115.40M
Receivables 128.16M 99.58M 72.74M 57.04M
Inventories 45.10M 47.77M 45.35M 17.28M
Other Current Assets 25.45M 9.75M 10.60M 12.14M
Total Current Assets 598.98M 395.96M 335.10M 244.92M
Property, Plant & Equipment, Gross 462.63M 404.78M 348.73M 277.45M
Accumulated Depreciation & Depletion 183.38M 140.40M 103.03M 71.90M
Property, Plant & Equipment, Net 279.25M 264.38M 245.69M 205.55M
Intangibles 7.13M 7.27M 10.57M 4.25M
Other Non-Current Assets 32.17M 39.33M 29.29M 8.57M
Total Non-Current Assets 349.89M 346.58M 328.75M 253.22M
Liabilities & Shareholder Equity
Total Assets 948.87M 742.54M 663.85M 498.13M
Accounts Payable 33.70M 31.07M 29.22M 14.80M
Short Term Debt 67.85M 59.09M 28.66M 263.00K
Other Current Liabilities 29.80M 12.80M 12.21M 15.14M
Total Current Liabilities 194.10M 147.42M 142.75M 59.57M
Long Term Debt 11.12M 5.70M 5.59M 37.72M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 8.89M 11.19M 9.78M 8.02M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 20.01M 16.89M 15.38M 45.74M
Total Liabilities 214.12M 164.31M 158.13M 105.30M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 734.75M 578.22M 505.73M 392.83M
Common Par 11.44M 11.22M 11.41M 11.22M
Additional Paid In Capital 353.17M 331.71M 345.83M 332.91M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 303.17M 188.60M 103.16M 22.18M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 66.96M 46.68M 45.32M 26.52M
Total Capitalization 745.87M 583.92M 511.32M 430.55M
Total Equity 734.75M 578.22M 505.73M 392.83M
Total Liabilities & Stock Equity 948.87M 742.54M 663.85M 498.13M
Total Common Shares Outstanding 71.53M 70.14M 71.31M 70.12M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 70.91M 71.05M 70.88M 69.54M
Diluted Weighted Shares Outstanding 72.75M 72.80M 75.44M 74.69M
Number of Employees 7445 6817 6046 4465
Number of Part-Time Employees 0 0 0 0
WX News

WX WuXi PharmaTech (Cayman) Inc

Analysts Ratings for WX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 6 6
Moderate Buy 0 0 0 0
Hold 3 3 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET WX ANALYST REPORT

Brokerage Partners

WX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs